Brought to you by 
Alector closes $29.5mm Series D round
08 Feb 2016
Executive Summary
Just four months after closing a $32mm Series C round, immunotherapeutics start-up Alector LLC (focused on dementia and neurodegeneration) raised $29.5mm through a Series D financing led by Dementia Discovery Fund; other new investors Amgen Ventures and AbbVie also participated, along with return backers Merck Research Lab Ventures, OrbiMed Advisors, Polaris Partners, Google Ventures (now known as GV), Topspin Partners, and Mission Bay Capital.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Alector closes $29.5mm Series D round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice